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SUMMARY OF THESIS*
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MACRONODULES IN CIRRHOTIC LIVER: MORPHOLOGICAL FINDINGS WITH EMPHASIS IN GROSS
FEATURES, PROLIFERATION AND APOPTOSIS
Aims: To study macronodules in explanted cirrhotic livers,
performing a detailed description of gross aspects and histological
features according to each type. To study proliferation, apoptosis and
regulatory proteins P53, Bcl-2, Bcl-x and Bax in these nodules. Material
and Methods: Sixty one consecutive liver explanted specimens, handled
by a single pathologist, following a pre-established protocol, were
prospectively inspected for macronodules. From each identified nodule,
a digital picture was examined to the following gross characteristics: a)
hue; b) color; c) color variability; d) circumscription; e) capsule; and f)
extra-capsular extension. International Working Party (1995) criteria were
applied to classify nodules as large regenerative nodule (LRN) low grade
dysplastic nodule (LGDN), high grade dysplastic nodule (HGDN), well
differentiated hepatocellular carcinoma (WHCC) and moderately
differentiated hepatocellular carcinoma (MHCC). Some histological
variables not included as diagnostic criteria were also evaluated. All
macronodules, 20 normal control livers and one additional section from
regular cirrhosis from each liver were immunostained for PCNA, P53,
Bcl-2 Bcl-x and Bax. Hematoxilin-eosin stained slides were used to count
apoptosis. Results: Thirty two cases (52.45%) had 96 macronodules,
including 13 (21.31%) with 21 hepatocellular carcinomas (HCC). Nine
livers with HCC had  other macronodules types, but four did not. Nodule
size progressively increase, from LRN to MHCC. The distribution was
similar in all kinds of lesions. Nine of 10 green color lesions were HCC
or HGDN, whereas 19 of 22 brownish lesions were LRN or LGDN.
Most lesions with high color variability were HCC. WHCC was
frequently ill circumscribed and had no capsule. All MHCC had well
circumscribed borders, and a thin capsule was the rule in LRN, MNR
and HGDN. Apparent extracapsular extension was only seen in HCC
and HGDN. Major fatty change was associated with HCC, specially
WHCC. Clear cells, Mallory bodies, interstitial fibrosis and siderosis
resistance were also HCC features. There was a steady increase of
proliferation from normal control liver to cancer. Apoptotic rate also
roughly increased along the spectrum of macronodules, but with a
flattened curve from cirrhosis to LGDN. P53 was immunodetected only
in four MHCC, whereas Bcl-2 was positive only in seven cases of
cirrhosis. Bcl-x was immunostained in a progressively reducing rate of
cases from HGDN to MHCC. Normal livers and HGDN did not express
Bax, but all other categories had a small percentage of positive cases.
Forty percent of MHCC had immunohistochemically detectable Bax in
cytoplasm. Conclusions: The steady increase in size, as well as in
proliferation and apoptotic rates from cirrhosis to HCC, suggests a
progression from each diagnostic class to the next. Although most HCC
develop in macronodules harboring livers, some of them do not,
suggesting an alternative pathway for hepatocarcinogenesis. The
following gross aspects were found useful in selecting the most suspicious
nodules: green color, marked color variation inside the nodule, and
extracapsular extension were found as indicators of HCC. Steatosis, clear
cells, Mallory bodies and intra - nodular fibrosis could be useful
histological criteria to HCC. The deficit of apoptotic rate as compared to
proliferation rate from cirrhosis to LGDN could reflect some
dysregulation in the cell population control. Different patterns of
expression of Bcl-2, Bcl-x and Bax could play a role in this process. P53
anomalous expression was present only in late stage of cancer
development.
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